U.S. Department of Veterans Affairs
Date of this Version
2016
Document Type
Article
Citation
Journal of Oncology Practice: Volume 12 / Issue 2 / February 2016
Abstract
Limited-stage small-cell lung cancer (SCLC) occurs in only one third of patients with SCLC, but it is potentially curable. Combined-modality therapy (chemotherapy and radiotherapy) has long been the main stay of therapy for this condition, but more recent data suggest a role for surgery in early-stage disease. Prophylactic cranial irradiation seems to improve outcomes in patients who have responded to initial therapy. This review addresses the practical aspects of staging and treatment of patients with limited-stage SCLC.
COinS
Comments
Copyright © 2016 by American Society of Clinical Oncology
This document is a U.S. government work and is not subject to copyright in the United States.
DOI: 10.1200/JOP.2015.009068